The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
Abstract
INTRODUCTION: Intravenously injected nanoparticles, like any other foreign pathogen that enters the body, encounter multiple lines of defense intended to neutralize and eliminate the invading substance. Adsorption of plasma proteins on the nanoparticle surface is the first barrier of defense, which could lead to physical changes in the formulation, such as aggregation and charge neutralization, biochemical activation of defense cascades, and trigger elimination by multiple types of phagocytic cell. AREAS COVERED: In this review, recent knowledge on the mechanisms that govern the interactions of nanoparticles (micelles, liposomes, polymeric and inorganic nanoparticles) with plasma proteins is discussed. In particular, the role of the nanoparticle surface properties and protective polymer coating in these interactions is described. The mechanisms of protein adsorption on different nanoparticles are analyzed and the implications on the clearance, toxicity and efficacy of drug delivery are discussed. The review provides readers with the biological insight into the plasma/blood interactions of nanoparticles. EXPERT OPINION: The immune recognition of nanoparticles can seriously affect the drug delivery efficacy and toxicity. There is at present not enough knowledge on the mechanisms that dictate the nanoparticle immune recognition and stability in the biological milieu. Understanding the mechanisms of recognition will become an important part of nanoparticle design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 2×
“With the renewed interest in nanotechnology, new nano-sized formulations and nanomaterials have been developed [2].”
BackgroundFactors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823 · cited 2×
“In addition to the decreased efficiency, the uptake of drug-loaded nanoparticles (NPs) can result in damage to the immune cells due to both drug and nanomaterial [6,12,13].”
BackgroundBangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,809
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Gorbet, M. B., & Sefton, M. V. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.01.023 · Cited by 1,347
MACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H.-H., Brown, G. D., & Gordon, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115816 · Cited by 1,324
What the Cell “Sees” in Bionanoscience
Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I., & Dawson, K. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910675v · Cited by 1,184
Identification of Tim4 as a phosphatidylserine receptor
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., & Nagata, S. (2007) · Nature · doi:10.1038/nature06307 · Cited by 1,180 · cited 1×
“Several new macrophage scavenger receptors for phosphatidylserine have been found recently [79,80], although these receptors are not expressed in the liver.”
BackgroundAnderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., et al. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300127-mcp200 · Cited by 1,006
Interaction of Gold Nanoparticles with Common Human Blood Proteins
Lacerda, S. H. D. P., Park, J. J., Meuse, C., Pristinski, D., Becker, M. L., Karim, A., & Douglas, J. F. (2010) · ACS Nano · doi:10.1021/nn9011187 · Cited by 976
Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces
Vroman, L., Adams, A., Fischer, G., & Munoz, P. (1980) · Blood · doi:10.1182/blood.v55.1.156.156 · Cited by 781
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
Abbruzzese, J. L., Grunewald, R., Weeks, E. A., Gravel, D., Adams, T., Nowak, B., Mineishi, S., Tarassoff, P., Satterlee, W., & Raber, M. N. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.491 · Cited by 759
Rabilloud, T. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200201)2:1<3::aid-prot3>3.0.co;2-r · Cited by 717
Lynch, I., Cedervall, T., Lundqvist, M., Cabaleiro-Lago, C., Linse, S., & Dawson, K. A. (2007) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2007.04.021 · Cited by 711
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Dobrovolskaia, M. A., Patri, A. K., Zheng, J., Clogston, J. D., Ayub, N., Aggarwal, P., Neun, B. W., Hall, J. B., & McNeil, S. E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.001 · Cited by 679
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie · doi:10.1002/ange.200700465 · Cited by 655
Nanoparticle‐induced platelet aggregation and vascular thrombosis
Radomski, A., Jurasz, P., Alonso‐Escolano, D., Drews, M., Morandi, M., Malinski, T., & Radomski, M. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706386 · Cited by 636
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
Szebeni, J. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.023 · Cited by 611
The lectin‐complement pathway – its role in innate immunity and evolution
Fujita, T., Matsushita, M., & Endo, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0123.x · Cited by 606
Lynch, I., Salvati, A., & Dawson, K. A. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.248 · Cited by 551
Greenwalt, D., Lipsky, R., Ockenhouse, C., Ikeda, H., Tandon, N., & Jamieson, G. (1992) · Blood · doi:10.1182/blood.v80.5.1105.1105 · Cited by 518
Mechanisms of Quantum Dot Nanoparticle Cellular Uptake
Zhang, L. W., & Monteiro-Riviere, N. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp087 · Cited by 499
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Self-citationChonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 460
Adsorbed Proteins Influence the Biological Activity and Molecular Targeting of Nanomaterials
Dutta, D., Sundaram, S. K., Teeguarden, J. G., Riley, B. J., Fifield, L. S., Jacobs, J. M., Addleman, S. R., Kaysen, G. A., Moudgil, B. M., & Weber, T. J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm217 · Cited by 447
Raynal, I., Prigent, P., Peyramaure, S., Najid, A., Rebuzzi, C., & Corot, C. (2004) · Investigative Radiology · doi:10.1097/01.rli.0000101027.57021.28 · Cited by 403
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Schousboe, I. (1985) · Blood · doi:10.1182/blood.v66.5.1086.1086 · Cited by 366
Repulsive interactions and mechanical stability of polymer-grafted lipid membranes
Needham, D., McIntosh, T. J., & Lasic, D. D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90112-y · Cited by 364
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Gessner, A., Lieske, A., Paulke, B. R., & Müller, R. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00081-4 · Cited by 356
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Ultrafine Particles Affect Experimental Thrombosis in an In Vivo Hamster Model
Nemmar, A., Hoylaerts, M. F., Hoet, P. H. M., Dinsdale, D., Smith, T., Xu, H., Vermylen, J., & Nemery, B. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200110-026oc · Cited by 347
Dos Santos, N., Allen, C., Doppen, A.-M., Anantha, M., Cox, K. A. K., Gallagher, R. C., Karlsson, G., Edwards, K., Kenner, G., Samuels, L., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.12.013 · Cited by 341
Szebeni, J., Alving, C. R., & Muggia, F. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.4.300 · Cited by 341
Differential plasma protein binding to metal oxide nanoparticles
Deng, Z. J., Mortimer, G., Schiller, T., Musumeci, A., Martin, D., & Minchin, R. F. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/45/455101 · Cited by 337
Micellar Hybrid Nanoparticles for Simultaneous Magnetofluorescent Imaging and Drug Delivery
Park, J., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801810 · Cited by 333
Cell response to dextran-derivatised iron oxide nanoparticles post internalisation
Berry, C. C., Wells, S., Charles, S., Aitchison, G., & Curtis, A. S. G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.12.046 · Cited by 313
Shen, Y., Jacobs, J. M., Camp, D. G., Fang, R., Moore, R. J., Smith, R. D., Xiao, W., Davis, R. W., & Tompkins, R. G. (2004) · Analytical Chemistry · doi:10.1021/ac034869m · Cited by 297
Systematic Surface Engineering of Magnetic Nanoworms for In vivo Tumor Targeting
Park, J., von Maltzahn, G., Zhang, L., Derfus, A. M., Simberg, D., Harris, T. J., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Small · doi:10.1002/smll.200801789 · Cited by 293
Self-citationAcute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge
Geys, J., Nemmar, A., Verbeken, E., Smolders, E., Ratoi, M., Hoylaerts, M. F., Nemery, B., & Hoet, P. H. M. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11566 · Cited by 291
Harashima, H., Sakata, K., Funato, K., & Kiwada, H. (1994) · Pharmaceutical Research · doi:10.1023/a:1018965121222 · Cited by 284
Moghimi, S. M., Porter, C. J. H., Muir, I. S., Illum, L., & Davis, S. S. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91869-e · Cited by 282
Gaur, U., Sahoo, S. K., De, T. K., Ghosh, P. C., Maitra, A., & Ghosh, P. K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00447-0 · Cited by 267
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
Moore, A., Weissleder, R., & Bogdanov, A. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070629 · Cited by 260
Moghimi, S. M., Muir, I. S., Illum, L., Davis, S. S., & Kolb-Bachofen, V (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90137-e · Cited by 259
Mattison, K. W., Dubin, P. L., & Brittain, I. J. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp980486u · Cited by 258
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 250
Doi, T., Higashino, K., Kurihara, Y., Wada, Y., Miyazaki, T., Nakamura, H., Uesugi, S., Imanishi, T., Kawabe, Y., & Itakura, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53971-5 · Cited by 243
Functional groups on polystyrene model nanoparticles: Influence on protein adsorption
Gessner, A., Lieske, A., Paulke, B., & Müller, R. H. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10371 · Cited by 239
Stability of PEI–DNA and DOTAP–DNA complexes: effect of alkaline pH, heparin and serum
Moret, I., Esteban Peris, J., Guillem, V. M., Benet, M., Revert, F., Dası́, F., Crespo, A., & Aliño, S. F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00415-1 · Cited by 236
Nagayama, S., Ogawara, K.-I., Fukuoka, Y., Higaki, K., & Kimura, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.036 · Cited by 225
Evaluation of Nanoparticle Aggregation in Human Blood Serum
Rausch, K., Reuter, A., Fischer, K., & Schmidt, M. (2010) · Biomacromolecules · doi:10.1021/bm100971q · Cited by 223
Hybrid PET-optical imaging using targeted probes
Nahrendorf, M., Keliher, E., Marinelli, B., Waterman, P., Feruglio, P. F., Fexon, L., Pivovarov, M., Swirski, F. K., Pittet, M. J., Vinegoni, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915163107 · Cited by 222
Dendrimers Bind Human Serum Albumin
Froehlich, E., Mandeville, J. S., Jennings, C. J., Sedaghat-Herati, R., & Tajmir-Riahi, H. A. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9011119 · Cited by 221
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221
Interactions of liposomes with the reticuloendothelial system
Hsu, M. J., & Juliano, R. L. (1982) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(82)90120-3 · Cited by 214
Moghimi, S. M., Hedeman, H., Muir, I. S., Illum, L., & Davis, S. S. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90105-h · Cited by 176
Chung, Y.-I., Kim, J. C., Kim, Y. H., Tae, G., Lee, S.-Y., Kim, K., & Kwon, I. C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.017 · Cited by 175
Nanoparticle-induced vascular blockade in human prostate cancer
Agemy, L., Sugahara, K. N., Kotamraju, V. R., Gujraty, K., Girard, O. M., Kono, Y., Mattrey, R. F., Park, J.-H., Sailor, M. J., Jimenez, A. I., et al. (2010) · Blood · doi:10.1182/blood-2010-03-274258 · Cited by 170
Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells
Thiele, L., Diederichs, J. E., Reszka, R. C., Merkle, H. P., & Walter, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00525-2 · Cited by 170
Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors
Kobzik, L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.367 · Cited by 169
Kim, H. R., Andrieux, K., Deloménie, C., Chacun, H., Appel, M., Desmaële, D., Taran, F., Georgin, D., Couvreur, P., & Taverna, M. (2007) · Electrophoresis · doi:10.1002/elps.200600694 · Cited by 168
Crosslinked Iron Oxides (CLIO)
Wunderbaldinger, P., Josephson, L., & Weissleder, R. (2002) · Academic Radiology · doi:10.1016/s1076-6332(03)80210-6 · Cited by 167
Chonn, A., Semple, S. C., & Cullis, P. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25845 · Cited by 165
Simberg, D., Park, J.-H., Karmali, P. P., Zhang, W.-M., Merkulov, S., McCrae, K., Bhatia, S. N., Sailor, M., & Ruoslahti, E. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.056 · Cited by 164
Self-citationEsmaeili, F., Ghahremani, M. H., Esmaeili, B., Khoshayand, M. R., Atyabi, F., & Dinarvand, R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.038 · Cited by 159
Moghimi, S. M., & Patel, H. M. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81372-3 · Cited by 156
Price, M., Cornelius, R. M., & Brash, J. L. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00330-3 · Cited by 152
Liu, J., Zeng, F., & Allen, C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.013 · Cited by 139
The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse
Yan, X., Kuipers, F., Havekes, L. M., Havinga, R., Dontje, B., Poelstra, K., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.137 · Cited by 138
Inhibition of Liposome-Induced Complement Activation by Incorporated Poly(Ethylene Glycol)-Lipids
Bradley, A. J., Devine, D. V., Ansell, S. M., Janzen, J., & Brooks, D. E. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0798 · Cited by 132
Labarre, D., Vauthier, C., Chauvierre, C., Petri, B., Müller, R., & Chehimi, M. M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.01.019 · Cited by 131
Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins
Guo, L., Hamilton, R. L., Goerke, J., Weinstein, J. N., & Havel, R. J. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34759-3 · Cited by 130
Simberg, D., Weisman, S., Talmon, Y., Faerman, A., Shoshani, T., & Barenholz, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302232200 · Cited by 129
Self-citationScavenger receptors: diverse activities and promiscuous binding of polyanionic ligands
Platt, N., & Gordon, S. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90156-9 · Cited by 128
Leroux, J., Jaeghere, F. D., Anner, B. M., Doelker, É., & Gurny, R. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00321-v · Cited by 127
Colorimetric Assay Method for Determination of the Tannin Acyl Hydrolase (EC 3.1.1.20) Activity
Mondal, K. C., Banerjee, D., Jana, M., et al. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5185 · Cited by 124
Ishida, T., Ichikawa, T., Ichihara, M., Sadzuka, Y., & Kiwada, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.011 · Cited by 117
服部, 敏., Kimura, K., Seyrek, E., & Dubin, P. L. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5129 · Cited by 107
Pedersen, M. B., Zhou, X., Larsen, E., Sørensen, U. B. S., Kjems, J., Nygaard, J. V., Nyengaard, J. R., Meyer, R. L., Boesen, T. P., & Vorup‐Jensen, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902214 · Cited by 106
Receptor versus non-receptor mediated clearance of liposomes
Scherphof, G. L., & Kamps, J. A. A. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00133-6 · Cited by 105
Intravenously Administered Lecithin Liposomes: A Synthetic Antiatherogenic Lipid Particle
Williams, K. J., Werth, V. P., & Wolff, J. A. (1984) · Perspectives in biology and medicine · doi:10.1353/pbm.1984.0031 · Cited by 99
The human macrophage mannose receptor is not a professional phagocytic receptor
Cabec, V. L., Emorine, L. J., Toesca, I. J., Cougoule, C., & Maridonneau‐Parini, I. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204705 · Cited by 93
Effects of Apolipoproteins A-IV and A-I on the Uptake of Phospholipid Liposomes by Hepatocytes
Bisgaier, C. L., Siebenkas, M. V., & Williams, K. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85022-6 · Cited by 83
Oh, K. S., Song, J. Y., Cho, S. H., Lee, B. S., Kim, S. Y., Kim, K., Jeon, H., Kwon, I. C., & Yuk, S. H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.021 · Cited by 82
Ameller, T., Marsaud, V., Legrand, P., Gref, R., BARRATT, G. M., & Renoir, J. (2003) · Pharmaceutical Research · doi:10.1023/a:1024418524688 · Cited by 79
Targeted binding of PLA microparticles with lipid-PEG-tethered ligands
Duncanson, W. J., Figa, M. A., Hallock, K., Zalipsky, S., Hamilton, J. A., & Wong, J. Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.044 · Cited by 75 · cited 1×
“Thus, there is an apparent decrease of affinity of surface-tethered ligands owing to the interference of the surrounding PEG brush layer [101].”
BackgroundComplement: Alive and Kicking Nanomedicines
Andersen, A. J., Hashemi, S. H., Andresen, T. L., Hunter, A. C., & Moghimi, S. M. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1045 · Cited by 72
Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor
Nagayama, S., Ogawara, K., Minato, K., Fukuoka, Y., Takakura, Y., Hashida, M., Higaki, K., & Kimura, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.025 · Cited by 68
Nicolazzi, C., Mignet, N., de la Figuera, N., Cadet, M., Ibad, R. T., Séguin, J., Scherman, D., & Bessodes, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00067-1 · Cited by 67
Hsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Chang, H., Yen, T., & Fang, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/40/405101 · Cited by 62
Oku, N., Tokudome, Y., Namba, Y., Saito, N., Endo, M., Hasegawa, Y., Kawai, M., Tsukada, H., & Okada, S. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00283-9 · Cited by 58
Borchard, G., & Kreuter, J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016010808522 · Cited by 57
Tandia, B.-M., Vandenbranden, M., Wattiez, R., Lakhdar, Z., Ruysschaert, J., & Elouahabi, A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00150-3 · Cited by 53
Complement Activation by Polymers Carrying Hydroxyl Groups
Arima, Y., Kawagoe, M., Toda, M., & Iwata, H. (2009) · ACS Applied Materials & Interfaces · doi:10.1021/am9005463 · Cited by 52
Identification of proteins mediating clearance of liposomes using a liver perfusion system
Harashima, H., Matsuo, H., & Kiwada, H. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00132-4 · Cited by 49
Rappleye, C. A., & Goldman, W. E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.10.001 · Cited by 41
In vitro evaluation of nanoparticles spleen capture
Demoy, M., Andreux, J. P., Weingarten, C., Gouritin, B., Guilloux, V., & Couvreur, P. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00068-5 · Cited by 35
Cornelius, R. M., Archambault, J., & Brash, J. L. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00083-2 · Cited by 33
Important role of serum proteins associated on the surface of particles in their hepatic disposition
Furumoto, K., Ogawara, K., Nagayama, S., Takakura, Y., Hashida, M., Higaki, K., & Kimura, T. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00196-7 · Cited by 31
Hong, Y., Shaw, P. J., Tattam, B. N., Nath, C. E., Earl, J. W., Stephen, K. R., & McLachlan, A. J. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0240-x · Cited by 22
Chacko, B. K., & Appukuttan, P. S. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00028-2 · Cited by 15
Falcone, D. J. (1986) · Journal of Leukocyte Biology · doi:10.1002/jlb.39.1.1 · Cited by 12
The role of β2-glycoprotein I in liposome–hepatocyte interaction
Yan, X., Morselt, H. W. M., Scherphof, G. L., Poelstra, K., & Kamps, J. A. A. M. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.10.008 · Cited by 6
Cited by
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D., & Chan, W. C. W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.020 · Cited by 1,349
Nanoparticle colloidal stability in cell culture media and impact on cellular interactions
Moore, T. L., Rodriguez-Lorenzo, L., Hirsch, V., Balog, S., Urban, D., Jud, C., Rothen-Rutishauser, B., Lattuada, M., & Petri-Fink, A. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00487f · Cited by 1,082
Yao, J., Yang, M., & Duan, Y. (2014) · Chemical Reviews · doi:10.1021/cr200359p · Cited by 944
Metadata
- Authors
- Karmali, P. P., & Simberg, D.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2011-02-04
- Volume
- 8
- Issue
- 3
- Pages
- 343-357
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2147816095
- Cited by
- 361
- References
- 116
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.